ProSomnus® Sleep Technologies Selected to Present at Digital Medicine and MedTech Showcase

ProSomnus® Sleep Technologies Selected to Present at Digital Medicine and MedTech Showcase

ProSomnus Sleep Technologies is the Leader in Precision Oral Appliance Therapy for OSA

San Francisco, CA, January 8, 2019Today, ProSomnus Sleep Technologies announced that they have been selected to present at the prestigious Digital Medicine and MedTech Showcase, January 7-9, 2019, in San Francisco, CA. This annual event is a forum that connects leaders in medicine with companies that are developing novel technologies to address important healthcare issues.

ProSomnus Sleep Technologies will utilize this opportunity to raise awareness of Obstructive Sleep Apnea (OSA), a serious medical condition that impacts over 25 Million US Adults, and how the company is using technology to enable better therapy. It is estimated that over 80% of OSA patients remain undiagnosed and untreated.

“Obstructive Sleep Apnea is a large, rapidly growing, public health issue that is largely unaddressed,” noted Len Liptak, CEO and Co-Founder of ProSomnus Sleep Technologies. “To scale this issue, OSA therapies need to be effective for everyday use, easy to prescribe, and economical. ProSomnus Sleep Devices are designed to help patients and providers achieve these goals.”

ProSomnus will discuss how digital manufacturing technologies are utilized to produce comfortable, precision, medical devices that are customized to the anatomy and prescription for each and every patient.

“OSA is a medical condition, diagnosed by a Medical Doctor, where dentists are the DME provider. ProSomnus devices enable the type of predictable performance that is expected by every member of the treatment team,” stated Mark T. Murphy, DDS, Lead Faculty for ProSomnus.

“Obstructive Sleep Apnea is a lifelong disease with serious co-morbidities that is under diagnosed and grossly under treated. In the past, the primary form of treatment was CPAP which is highly efficacious, but its effectiveness is compromised by poor compliance,” stated Edward T. Sall, MD, DDS, MBA, Medical Director for ProSomnus. “ProSomnus Oral Appliances are highly effective in the treatment of OSA due to their high compliance in patients. Since OSA is a lifelong disease, treatment with the ProSomnus Oral Appliance represents a paradigm shift to a global problem of over 1 Billion people with OSA.”

About ProSomnus Sleep Technologies ProSomnus® Sleep Technologies designs, manufactures and markets FDA Cleared Class II Medical Devices for the treatment of Obstructive Sleep Apnea. Diagnosed by Medical Doctors and provided by Dentists, ProSomnus Devices are the first, precision oral appliance therapy devices designed to enhance compliance, mitigate side effects and, enable providers to achieve excellent patient experiences and outcomes. They have been used to treat thousands of patients, with clinical performance that has been validated in numerous studies.

Media Contact Heather Whalen, VP Marketing hwhalen@prosomnus.com
1-844-53SLEEP | 5860 West Las Positas Blvd., Suite 25, Pleasanton, CA 94588 | ProSomnus.com

Stay Relevant With Dental Sleep Practice

Join our email list for CE courses and webinars, articles and more..

Shopping Cart
Scroll to Top